NPR logo

Vioxx Sparks Debate over Malpractice Reform

  • Download
  • <iframe src="https://www.npr.org/player/embed/4181355/4181356" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Vioxx Sparks Debate over Malpractice Reform

U.S.

Vioxx Sparks Debate over Malpractice Reform

Vioxx Sparks Debate over Malpractice Reform

  • Download
  • <iframe src="https://www.npr.org/player/embed/4181355/4181356" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Following the recent removal of the drug Vioxx from the market, lawmakers are reconsidering a portion of medical malpractice reform. Caps in the malpractice bill would affect pharmaceutical and medical product manufacturers. Democrats oppose the caps, but Sen. Orrin Hatch (R-UT) calls the situation a "feeding frenzy" for trial lawyers. NPR's Julie Rovner reports.

We no longer support commenting on NPR.org stories, but you can find us every day on Facebook, Twitter, email, and many other platforms. Learn more or contact us.